Naproxen Sodium And Pseudoephedrine Hydrochloride Sinus And Headache 58602-0832
Generic: Naproxen Sodium And Pseudoephedrine Hydrochloride
Product NDC
58602-0832- Manufacturer
- Aurohealth Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- June 1, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA211360
Active Ingredients
| Ingredient | Strength |
|---|---|
| Naproxen Sodium | 220 mg/1 |
| Pseudoephedrine Hydrochloride | 120 mg/1 |
Drug Class
Adrenergic alpha-Agonists [MoA]Anti-Inflammatory AgentsNon-Steroidal [CS]
Packaging Options(2)
2 BLISTER PACK in 1 CARTON (58602-832-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
1 BLISTER PACK in 1 CARTON (58602-832-83) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
External Resources